Reema Goel

Summary

Affiliation: Blood Research Institute
Country: USA

Publications

  1. ncbi The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis
    Reema Goel
    Blood Research Institute, BloodCenter of Wisconsin, P O Box 2178, Milwaukee, WI 53201, USA
    Am J Physiol Gastrointest Liver Physiol 293:G1205-14. 2007
  2. ncbi Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice
    Reema Goel
    Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI 53201, USA
    Arterioscler Thromb Vasc Biol 28:1996-2002. 2008
  3. ncbi The cell-adhesion and signaling molecule PECAM-1 is a molecular mediator of resistance to genotoxic chemotherapy
    Carmen Bergom
    Blood Research Institute, Blood Center of Wisconsin, and Department of Cell Biology, Medical College of Wisconsin, Milwaukee, Wisconsin 53201, USA
    Cancer Biol Ther 5:1699-707. 2006

Detail Information

Publications3

  1. ncbi The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis
    Reema Goel
    Blood Research Institute, BloodCenter of Wisconsin, P O Box 2178, Milwaukee, WI 53201, USA
    Am J Physiol Gastrointest Liver Physiol 293:G1205-14. 2007
    ..Future examination of recently identified PECAM-1 allelic isoforms in humans as potential risk factors for developing NASH may be warranted...
  2. ncbi Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice
    Reema Goel
    Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI 53201, USA
    Arterioscler Thromb Vasc Biol 28:1996-2002. 2008
    ..PECAM-1 also inhibits inflammatory responses, on which basis it is predicted to be atheroprotective...
  3. ncbi The cell-adhesion and signaling molecule PECAM-1 is a molecular mediator of resistance to genotoxic chemotherapy
    Carmen Bergom
    Blood Research Institute, Blood Center of Wisconsin, and Department of Cell Biology, Medical College of Wisconsin, Milwaukee, Wisconsin 53201, USA
    Cancer Biol Ther 5:1699-707. 2006
    ..In addition, reducing PECAM-1 levels in the tumor endothelium may aid in low-dose, anti-angiogenic therapy...